Brind.

Institutional Investors Increase Stakes in Johnson & Johnson

2 reports, 2 independent Updated Oct 24
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Several large investment firms increased their holdings in Johnson & Johnson during the first, second, and third quarters of 2026. Amundi grew its shares by 17.5% in the first quarter, while Contravisory Investment Management Inc. increased its stake by 54.2% in the third quarter, according to Holdings Channel.com reports. Other firms that boosted their positions include Wellington Management Group LLP and Deutsche Bank AG.

From themarketsdaily.com

Why it matters

Some supportBrind's analysis of the reports

The increase in institutional investment suggests confidence in Johnson & Johnson's valuation and future performance. These large-scale purchases by firms like Amundi and Contravisory Investment Management Inc. reflect significant capital flow into the company.

From themarketsdaily.com

Who's involved

  • Johnson & JohnsonU.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

How it developed

Newest first. Tap a step to see who reported it.
  1. RBC lowered JNJ price target and RJF set a new target, while Amundi boosted its holdings.1 source
  2. Multiple financial institutions issued rating upgrades and price target increases for Johnson & Johnson.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped